Indian scientists have discovered a new formula from this protein which can change the lives of diabetic patients.

A team of Indian scientists has discovered a new way to treat diabetes. They have developed a protein that can prevent the damage caused by diabetes. Researchers have discovered a specific protein, IL-35, which reduces cells that produce chemicals that cause inflammation. This reduces the effect of pancreatic cells. This process contributes positively and significantly to type 1 diabetes and autoimmune diabetes mellitus.

Researchers from the Institute for Advanced Study in Science and Technology under the Central Government have made this discovery. According to the researchers, these findings mean that IL-35 protects the immune system. It also provides a new treatment option for diabetes. However, further studies are needed to understand this entire mechanism and advance the IL-35-based drug into clinical trials.

What do researchers say?
Researchers say children and adolescents in developing countries around the world are being affected by the diabetes epidemic. In such a situation, effective treatment of diabetes is the need of the hour. IL-35 is a distinct class of proteins, encoded by the IL-12A and EBI-3 genes. According to the research, this discovery has increased scientists' interest in IL-35, especially in new type-1 and autoimmune diabetes treatments.

Dr. Ashish Bala, Associate Professor (Institute for Advanced Study in Science and Technology), an autonomous institute under the Government of India, Guwahati, Director and Prof. The studies related to Ashish K Mukherjee and IL-35 were reviewed by research scholar Ratul Chakraborty for the pharmacological analysis of the gene, gene-disease relevance and detailed application. This analysis identified five disease-modifying genes associated with immune-inflammatory, autoimmune, neoplastic and endocrine disorders.

What IL-35 Can Help According to researchers, IL-35 helps prevent type 1 and autoimmune diabetes. It controls macrophage activation, T-cell proteins, and regulatory B cells. IL-35 prevents pancreatic beta cells from influencing immune cells. Additionally, IL-35 reduces certain immune cells that produce inflammatory chemicals. It reduces pancreas cell dysfunction which is a major contributor to type 1 diabetes and autoimmune diabetes mellitus.